ProtonDx operates in the molecular diagnostics and life sciences sector, developing rapid, portable testing technologies for human health, animal health, food safety and research applications. Its Dragonfly platform enables point-of-care, multi-pathogen detection without the need for additional benchtop equipment, supporting uses such as respiratory, malaria and custom test panels. The company also provides nucleic acid extraction products using proprietary magnetic bead-based systems, alongside bespoke research and development solutions. Its services are aimed at laboratories, healthcare settings, veterinary and agricultural users, and organisations needing fast, sensitive pathogen testing in field or near-patient environments.